Protagenic Therapeutics Inc (NASDAQ:PTIX) currently has a daily average trading volume of 21.02K but it saw 1302939 shares traded in last market. With a market cap of 4.47M USD, the company’s current market price of $1.00 came falling about -2.91 while comparing to the previous closing price of $1.03. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.98 and as low as $0.50. In the recent trading on the day, stock has struck highest price mark of $0.888 while lowest mark touched by it was $1.1099.
Taking a look at 20-day trading activity of Protagenic Therapeutics Inc (PTIX) gives us an average price of $0.6857, while its current price level is -49.49% below from 52-week high level whereas it is 100.00% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.7094 while that of 200 days or SMA-200 reads an average of $1.0162. A closer look into the stock’s movement over the week reveals that its volatility is standing at 20.36% during that period while stretching the period over a month that decreases to 19.37%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 70.01 which implies that the stock is in overbought territory.
Over the week, PTIX’s stock price is moving 66.11% up while it is 58.73% when we observe its performance for the past one month. Year-to-date it is 1.01% up and over the past year, the stock is showing a downside performance of -46.81%.
Currently, Protagenic Therapeutics Inc’s total number of outstanding shares is 4.44M. Company’s return on investment (ROI) stands at -808.01% and return on equity (ROE) at -206.36%. Stock has a price to book (P/B) ratio of 5.64. Its return on asset (ROA) is -152.72% on average.
